Cerebrovascular Diseases

AXIOMATIC-SSP is considered the largest clinical trial of activated factor XIa inhibition added to standard antiplatelet therapy for secondary stroke prevention.

One-half of more than 600 000 patients with ASCVD were not prescribed statins at all and only 22.5% were taking a high intensity statin, according to a recent study.

AHA 2021: E-cigarette users were found to have a 15% higher risk of a cerebrovascular accident at a younger age than those who smoked combustible tobacco cigarettes.

The temporal connection of atrial fibrillation and risk of ischemic stroke provides support for short-duration oral anticoagulation, said study authors.

Four major cardiology organizations stand behind increased government action to eradicate tobacco use worldwide. Click here for a summary of why, why now, and how.

Sex disparities in cardiovascular care in the VA system included less therapy with antiplatelet agents and any intensity statin for women with premature ASCVD than men.

FDA approval is based on results of the phase III THALES trial, in which DAPT with ticagrelor and aspirin for 30 days reduced the rate of stroke and death by 17% vs aspirin alone.

"Beyond hypertension, higher BPV is a major clinical predictor of cognitive impairment and dementia," conclude authors of a new study.

That depends, as suggested by results of the CASTLE-AF study, presented at ESC Congress 2017, in Barcelona, Spain.

Diagnosis of atrial fibrillation via handheld iECG monitor looks promising but can we pay for it yet?

Mr Smith is 66-years-old. How would you treat his arrhythmia? What would you choose for anticoagulation?

Digoxin is used in nearly 30% of patients with AF but has never been studied for safety/efficacy in this population, until now.

Is exercise safe in HF patients who have AF? Results of the HF-ACTION study are summarized in this short slide show.

A study of a global registry finds that prescriptions for direct oral anticoagulants have now surpassed those for VKAs. What do you Rx?

Patients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start.

In these complicated patients, should warfarin or a novel oral anticoagulant be chosen for stroke prevention?

Is aspirin safe as antithrombotic therapy in pregnancy? Is electrocardioversion first-line treatment? Get the answers and other reminders, here.

Implantable cardiac monitoring devices now detect "silent" AF. But now that we "hear" it, what should we do?

A signal for increased risk of hemorrhage when the NOAC is coadministered with 2 statins comes as a surprise to some.

Tachy-brady syndrome can be a particular management challenge in an elderly patient. How would you manage Mrs Robertson?

Concurrence of AF and SSS is common in older patients and presents a treatment conundrum. Can you balance safety and efficacy in this patient?

Catch up on current guideline recommendations in this quick question and answer with Kaiser Permanente cardiologist Payal Kohli, MD.

Drivers with AF hospitalized after a car accident are at greater risk of death than those without AF. Who gets a red light?

Is prevalence of atrial fibrillation higher in men or women? Which sex is more likely to be asymptomatic? At higher risk for stroke?

Ablation has become a leading option to arrest AF in many patients. Try 3 quick questions to test your ablation quotient.

Although results of the hypertension portion of HOPE-3 were disappointing, many caveats are offered to explain the outcome.

Results of a large Taiwanese registry analysis could open discussion around avoidance of oral anticoagulants in post-ICH patients.

Critics continue to call for independent analysis by outside investigators not involved with the original trial.

Find data here on obesity, exercise, and OSA, plus 4 more factors that increase the risk for AF and other CV disease.